{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T08:22:00Z","timestamp":1716020520730},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U19 AI057319"],"award-info":[{"award-number":["U19 AI057319"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.12.036","type":"journal-article","created":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T09:13:53Z","timestamp":1293873233000},"page":"1666-1676","source":"Crossref","is-referenced-by-count":5,"title":["Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines"],"prefix":"10.1016","volume":"29","author":[{"given":"Sharone","family":"Green","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis A.","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2010.12.036_bib0005","first-page":"397","article-title":"Smallpox: emergence, global spread, and eradication","volume":"15","author":"Fenner","year":"1993","journal-title":"History and Philosophy of the Life Sciences"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2010.12.036_bib0010","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","article-title":"The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program","volume":"23","author":"Poland","year":"2005","journal-title":"Vaccine"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2010.12.036_bib0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/rmv.571","article-title":"New generation smallpox vaccines: a review of preclinical and clinical data","volume":"18","author":"Artenstein","year":"2008","journal-title":"Reviews in Medical Virology"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2010.12.036_bib0020","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1586\/14760584.7.8.1225","article-title":"Smallpox vaccines for biodefense: need and feasibility","volume":"7","author":"Artenstein","year":"2008","journal-title":"Expert Review of Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.036_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1348-0421.1985.tb00843.x","article-title":"Gene structures of low-neurovirulent vaccinia virus LC16m0, LC16m8, and their Lister original (LO) strains","volume":"29","author":"Sugimoto","year":"1985","journal-title":"Microbiology and Immunology"},{"key":"10.1016\/j.vaccine.2010.12.036_bib0235","first-page":"24","article-title":"Changes in the vaccinia virus through continuing passages in chick embryo fibroblast cultures","volume":"195","author":"Mayr","year":"1964","journal-title":"Zentralblatt f\u00fcr Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2010.12.036_bib0035","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1055\/s-0028-1108143","article-title":"MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)","volume":"99","author":"Stickl","year":"1974","journal-title":"Deutsche medizinische Wochenschrift"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2010.12.036_bib0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2010.12.036_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2005.06.043","article-title":"The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection","volume":"341","author":"Coulibaly","year":"2005","journal-title":"Virology"},{"issue":"March (6979)","key":"10.1016\/j.vaccine.2010.12.036_bib0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"August (31)","key":"10.1016\/j.vaccine.2010.12.036_bib0055","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2010.12.036_bib0060","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.vaccine.2007.12.059","article-title":"Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine","volume":"26","author":"Ferrier-Rembert","year":"2008","journal-title":"Vaccine"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2010.12.036_bib0065","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/421266","article-title":"Modified vaccinia Ankara: potential as an alternative smallpox vaccine","volume":"38","author":"McCurdy","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"September (2)","key":"10.1016\/j.vaccine.2010.12.036_bib0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","article-title":"Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model","volume":"339","author":"Meseda","year":"2005","journal-title":"Virology"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2010.12.036_bib0075","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"Journal of Virology"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2010.12.036_bib0080","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.vaccine.2005.11.022","article-title":"Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","volume":"24","author":"Vollmar","year":"2006","journal-title":"Vaccine"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2010.12.036_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antiviral Research"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2010.12.036_bib0090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"The Journal of General Virology"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2010.12.036_bib0095","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2006.02.012","article-title":"Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA)","volume":"24","author":"Abdalrhman","year":"2006","journal-title":"Vaccine"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2010.12.036_bib0100","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2006.10.047","article-title":"Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naive and vaccinia-immune individuals","volume":"25","author":"Parrino","year":"2007","journal-title":"Vaccine"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2010.12.036_bib0105","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.4049\/jimmunol.181.9.6371","article-title":"Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling","volume":"181","author":"Meyer","year":"2008","journal-title":"Journal of Immunology"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.12.036_bib0110","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/JVI.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus","volume":"70","author":"Demkowicz","year":"1996","journal-title":"Journal of Virology"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.12.036_bib0115","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nature Medicine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.036_bib0120","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/1521-4141(200206)32:6<1567::AID-IMMU1567>3.0.CO;2-P","article-title":"Defective generation but normal maintenance of memory T cells in old mice","volume":"32","author":"Kapasi","year":"2002","journal-title":"European Journal of Immunology"},{"issue":"June","key":"10.1016\/j.vaccine.2010.12.036_bib0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.0105-2896.2006.00385.x","article-title":"T-cell memory and recall responses to respiratory virus infections","volume":"211","author":"Hikono","year":"2006","journal-title":"Immunological Reviews"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.12.036_bib0130","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.20070322","article-title":"Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells","volume":"204","author":"Hikono","year":"2007","journal-title":"The Journal of Experimental Medicine"},{"issue":"10","key":"10.1016\/j.vaccine.2010.12.036_bib0135","doi-asserted-by":"crossref","first-page":"e3323","DOI":"10.1371\/journal.pone.0003323","article-title":"Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus","volume":"3","author":"Mathew","year":"2008","journal-title":"PloS One"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.036_bib0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"The Journal of Experimental Medicine"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2010.12.036_bib0145","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.4049\/jimmunol.174.4.2212","article-title":"Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles","volume":"174","author":"Mathew","year":"2005","journal-title":"Journal of Immunology"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2010.12.036_bib0150","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2010.12.036_bib0155","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.4049\/jimmunol.180.8.5309","article-title":"Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1","volume":"180","author":"Chandele","year":"2008","journal-title":"Journal of Immunology"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.12.036_bib0160","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.4049\/jimmunol.161.12.6451","article-title":"Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell function-associated antigen, an inhibitory C-type lectin","volume":"161","author":"Blaser","year":"1998","journal-title":"Journal of Immunology"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.036_bib0165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.20071641","article-title":"Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates","volume":"205","author":"Sarkar","year":"2008","journal-title":"The Journal of Experimental Medicine"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2010.12.036_bib0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.12.036_bib0175","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0531-5565(03)00134-7","article-title":"Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1)","volume":"38","author":"Ouyang","year":"2003","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.vaccine.2010.12.036_bib0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.immunol.021908.132625","article-title":"Immunity to respiratory viruses","volume":"27","author":"Kohlmeier","year":"2009","journal-title":"Annual Review of Immunology"},{"issue":"February (10)","key":"10.1016\/j.vaccine.2010.12.036_bib0185","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.vaccine.2006.11.017","article-title":"Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge","volume":"25","author":"Hooper","year":"2007","journal-title":"Vaccine"},{"issue":"June (23)","key":"10.1016\/j.vaccine.2010.12.036_bib0190","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.vaccine.2008.03.044","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination","volume":"26","author":"Jentarra","year":"2008","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.036_bib0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/095632020101200105","article-title":"Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir","volume":"12","author":"Smee","year":"2001","journal-title":"Antiviral Chemistry & Chemotherapy"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2010.12.036_bib0200","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"Journal of Virology"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.036_bib0205","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/eji.200838815","article-title":"Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model","volume":"39","author":"Moutaftsi","year":"2009","journal-title":"European Journal of Immunology"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.12.036_bib0210","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.01280-06","article-title":"Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry","volume":"81","author":"Cornberg","year":"2007","journal-title":"Journal of Virology"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2010.12.036_bib0215","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.4049\/jimmunol.180.3.1309","article-title":"Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation","volume":"180","author":"Joshi","year":"2008","journal-title":"Journal of Immunology"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2010.12.036_bib0220","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.4049\/jimmunol.175.3.1665","article-title":"During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion","volume":"175","author":"Hendriks","year":"2005","journal-title":"Journal of Immunology"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.12.036_bib0225","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/eji.200425770","article-title":"Properties of murine (CD8+)CD27\u2212 T cells","volume":"35","author":"Baars","year":"2005","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.vaccine.2010.12.036_bib0230","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1172\/JCI40178","article-title":"CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production","volume":"120","author":"Peperzak","year":"2010","journal-title":"The Journal of Clinical Investigation"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T18:14:26Z","timestamp":1685902466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10018098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10018098"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}